By Jeff Zalesin ( February 19, 2016, 5:42 PM EST) -- Teva Pharmaceutical Industries Ltd. has made commitments to the European Commission in an effort to win antitrust approval for the drugmaker's proposed, $40.5 billion acquisition of Allergan PLC's generics business, the commission said Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.